US › Healthcare

AtriCure Inc (ATRC)

US · Healthcare · Medical Instruments & Supplies

$39.00+0.72%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$153.6M
Revenue YoY
+12.8%
Net profit
$9.0M
Profit YoY
+244.7%
EPS
$0.18
EPS estimate
$0.03
Net margin
5.8%

EPS came in at 0.18 against a street estimate of 0.03 — a beat of 500.0%.

Key statistics

Market cap
$1.97B
P/E
184.4
Forward P/E
208.3
P/B
3.72
Book value
$10.15
EPS (TTM)
$0.21
52-week high
$43.18
52-week low
$25.36
50-day MA
$31.04
200-day MA
$33.14
Beta
1.23

Analyst view

Analysts rate AtriCure Inc a buy (7 buy, 2 hold, 0 sell out of 9) with an average price target of $47.33.

Shareholding

Insiders
3.84%
Institutions
101.74%

Largest institutional holders

FundStake
Vanguard Group Inc9.68%
BlackRock Inc7.98%
Wellington Management Company LLP6.68%
AllianceBernstein L.P.6.44%
Hood River Capital Management LLC6.16%
Vanguard Portfolio Management, LLC5.34%
Vanguard Capital Management, LLC4.26%
Delaware Management Holdings Inc3.56%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for AtriCure Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.